Patent covers compositions and methods of use of drug formulation for Zabalafin Hydrogel ANNAPOLIS, Md., Dec. 10, 2024 /PRNewswire/ --  Alphyn, a clinical-stage dermatology company developing first-in ...

Brittany Lancellotti, DVM, DACVD, talks about available treatment options for flea allergies, environmental allergies, and more ...

Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.

Astria Therapeutics (ATXS) announced the FDA clearance of its investigational new drug, or IND, application for STAR-0310, a monoclonal ...

Investing.com-- Oppenheimer slashed its price target on Q32 Bio Inc (NASDAQ:QTTB) after the firm released mixed results from ...

The Bergendorff scholarship was founded in 2022 in honor of Anders Bergendorff, the former program director of the master ...

Atopic dermatitis, commonly known as eczema, is a chronic skin condition that affects roughly one in five Canadians at some ...

Shares of Q32 Bio were touching all-time lows in the after-hours market following results from a pair of Phase 2a clinical trials of the company's alopecia treatment bempikibart.

"Eczema-prone skin lacks natural oils and moisture but the good news is that there are several ingredients that can make a huge difference," says Dr Sommerlad.

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced topline results from the ...

London: GSK plc has announced that the National Medical Products Administration (NMPA) of China has accepted for review a new ...

Ashley S. Bourgeois, DVM, DACVD, presented a lecture on cytology at the 2024 Fetch Long Beach conference in Long Beach, California ...